The consolidation brings together two organizations with a history of robust growth and performance ready to build on this strength using the outstanding talent of both companies to deliver enhanced ...

ICON has agreed to acquire PRA Health Sciences for approximately $12 billion in cash and stock, the companies said, in a deal that continues the consolidation of contract research organizations (CROs) ...

Icon PLC, a provider of outsourced drug and device development to the drug and medical device industries, said Wednesday it has agreed to acquire PRA Health Sciences Inc. in a cash and stock deal ...

Shares of PRA Health Sciences jumped nearly 18.7% on Feb. 24 after the research company inked a deal with ICON plc to be acquired in a cash-and-stock deal worth $12 billion. Per the terms of the ...

The PRA acquisition deal is a combination of cash and stock. According to terms announced Wednesday, PRA shareholders will receive $80 cash for each share of PRA that they own, plus 0.4125 shares in ...

Clinical-trial operator Icon PLCICLR0.48%increase; green up pointing triangle said it would acquire rival PRA Health Sciences Inc. for $12 billion, creating a powerhouse provider of services to ...